Alicia C. Olivo - 01 Aug 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Signature
/s/ Alicia C. Olivo
Issuer symbol
NEO
Transactions as of
01 Aug 2025
Net transactions value
$0
Form type
4
Filing time
05 Aug 2025, 16:38:59 UTC
Previous filing
13 May 2025
Next filing
03 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Olivo Alicia C EVP, GC & Business Development 9490 NEOGENOMICS WAY, FORT MYERS /s/ Alicia C. Olivo 05 Aug 2025 0001951869

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Tax liability $0 -14 -0.03% $0.000000 49,606 01 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 1,046 01 Aug 2025 Common Stock 1,046 $19.12 Direct F2
holding NEO Stock Option (Right to Buy) 1,024 01 Aug 2025 Common Stock 1,024 $27.34 Direct F3
holding NEO Stock Option (Right to Buy) 516 01 Aug 2025 Common Stock 516 $48.99 Direct F4
holding NEO Stock Option (Right to Buy) 1,117 01 Aug 2025 Common Stock 1,117 $46.10 Direct F5
holding NEO Stock Option (Right to Buy) 22,222 01 Aug 2025 Common Stock 22,222 $9.45 Direct F6
holding NEO Stock Option (Right to Buy) 55,332 01 Aug 2025 Common Stock 55,332 $10.05 Direct F7
holding NEO Stock Option (Right to Buy) 36,508 01 Aug 2025 Common Stock 36,508 $19.65 Direct F8
holding NEO Restricted Stock Unit 6,503 01 Aug 2025 Common Stock 6,503 $0.000000 Direct F9, F10
holding NEO Performance Stock Unit 19,508 01 Aug 2025 Common Stock 19,508 $0.000000 Direct F10, F11
holding NEO Stock Option (Right to Buy) 42,344 01 Aug 2025 Common Stock 42,344 $16.45 Direct F12
holding NEO Restricted Stock Unit 59,382 01 Aug 2025 Common Stock 59,382 $0.000000 Direct F10
holding NEO Performance Stock Unit 25,330 01 Aug 2025 Common Stock 25,330 $0.000000 Direct F10, F13
holding NEO Restricted Stock Unit 16,886 01 Aug 2025 Common Stock 16,886 $0.000000 Direct F10, F14
holding NEO Stock Option (Right to Buy) 107,450 01 Aug 2025 Common Stock 107,450 $13.05 Direct F15, F16
holding NEO Restricted Stock Unit 63,238 01 Aug 2025 Common Stock 63,238 $0.000000 Direct F10, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the August 1, 2025 vesting of restricted stock.
F2 On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F3 On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4 On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5 On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6 On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F7 On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F8 On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F9 On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10 Once vested, the shares of common stock are not subject to expiration.
F11 On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F12 On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F13 On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F14 On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F15 This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
F16 On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F17 On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.